drugset / Trial / NCT02111330
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
Study to assess the safety and tolerability of three doses of PBF-509 (80 mg, 160 mg and 240 mg) after repeated (8 days) single daily oral dose administration in young male and female healthy subjects.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBF-509 | Unknown | 80 mg | Oral |
| Subject | PBF-509 | Unknown | 160 mg | Oral |
| Subject | PBF-509 | Unknown | 240 mg | Oral |